Kinapse

Kinapse operates as a specialized advisory and operational services provider catering to the global life sciences industry. Established in 2005 by a team of professionals from the biopharmaceutical sector, including Andy Black, Nicholas Edwards, Shalabh Kumar, and others, the firm was built to address the increasing demand for outsourced expertise in the pharmaceutical world. Shalabh Kumar, a co-founder with a background in mechanical engineering from IIT Delhi and an MBA from IIM Calcutta, previously worked in strategy at Accenture and held operational roles at Unilever and Gillette before becoming CEO of Kinapse in 2009.

The company's business model is centered on a distinct "Advise – Build – Operate" framework, providing end-to-end support across the entire clinical and commercialization lifecycle of a product. Kinapse generates revenue by offering consulting and outsourcing services to a clientele that includes many of the world's top 20 global biopharmaceutical companies, as well as biotechnology firms and medical device manufacturers. The firm guides clients in analyzing, implementing, and executing a wide array of projects and programs. Its services focus on high-stakes areas such as regulatory affairs, pharmacovigilance and drug safety, medical writing, clinical trial transparency, quality and compliance, medical affairs, and market access. This focus became particularly relevant as major pharmaceutical companies restructured following the 'patent cliff'.

A significant milestone in the company's history was its acquisition by Syneos Health in August 2018 for approximately $100.1 million, a move designed to enhance Syneos Health's end-to-end biopharmaceutical solutions. Prior to this, Kinapse had experienced substantial growth, securing private equity investment from Synova Capital in 2012 and later being acquired by HgCapital in 2016. Under Synova's ownership, the company expanded internationally, opening offices in the US and Asia, and saw its annual sales grow from £6.5m to £27.5m. By 2014, it was recognized as one of the UK's fastest-growing companies by The Sunday Times Fast Track 100. Following the acquisition, Kinapse's operations were integrated into Syneos Health's consulting business, bolstering its capabilities in key outsourcing areas and doubling its consulting footprint in Europe.

Keywords: life sciences consulting, biopharmaceutical services, clinical lifecycle support, commercialization services, regulatory affairs outsourcing, pharmacovigilance services, medical writing, clinical trial disclosure, quality and compliance pharma, medical affairs consulting, market access strategy, Syneos Health, drug development outsourcing, pharma operational support, Advise-Build-Operate model, pharma advisory, biotechnology consulting, medical device services, clinical operations support, post-market surveillance